| P50 | author | Peter C. Whybrow | Q2074257 |
| | Michael Bauer | Q56953337 |
| | Paul Grof | Q91476141 |
| | Emanuel Severus | Q100296720 |
| | Tasha Glenn | Q114369954 |
| | Kemal Sagduyu | Q114369971 |
| P2093 | author name string | Martin Alda | |
| | Philipp Ritter | |
| | Rodrigo Munoz | |
| | Wendy Marsh | |
| P2860 | cites work | Quality of life in bipolar disorder: a review of the literature | Q25257218 |
| | An overview of psychotropic drug-drug interactions | Q28270894 |
| | The impact of medication regimen factors on adherence to chronic treatment: a review of literature | Q30436145 |
| | Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. | Q30956433 |
| | Mixed states vs. pure mania in the French sample of the EMBLEM study: results at baseline and 24 months--European mania in bipolar longitudinal evaluation of medication | Q33462011 |
| | Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis | Q33529314 |
| | The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study | Q33850634 |
| | National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 |
| | Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. | Q34098311 |
| | Psychopharmacological Treatment Status in Outpatients with Bipolar Disorder: A Clinical Survey in Germany | Q34165024 |
| | Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis | Q34304735 |
| | Brief depressive symptoms in patients with bipolar disorder: analysis of long-term self-reported data | Q34317237 |
| | Some current factors influencing the prescribing and use of psychiatric drugs | Q34454392 |
| | How often is medication taken as prescribed? A novel assessment technique | Q34525872 |
| | Treatment non-adherence in affective disorders. | Q34592227 |
| | Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence | Q34597937 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania | Q34606256 |
| | Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. | Q34634154 |
| | Overtreatment in adults with epilepsy | Q35006397 |
| | Polytherapy in bipolar disorder | Q36361982 |
| | Interactions between antiepileptic and antipsychotic drugs | Q36384715 |
| | Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials | Q37219379 |
| | Subsyndromal mood symptoms: a useful concept for maintenance studies of bipolar disorder? | Q37628396 |
| | Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients. | Q37723434 |
| | Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder | Q38003196 |
| | Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. | Q38383710 |
| | Factors associated with treatment nonadherence among US bipolar disorder patients | Q40146888 |
| | Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder | Q42869342 |
| | Disruptive insights in psychiatry: transforming a clinical discipline | Q43154189 |
| | Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study | Q43906035 |
| | Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009. | Q44237722 |
| | Self-reporting software for bipolar disorder: validation of ChronoRecord by patients with mania | Q45154142 |
| | Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians | Q46714706 |
| | Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy | Q46901295 |
| | Using technology to improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder | Q48600493 |
| | The association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer in bipolar disorder. | Q50714479 |
| | Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. | Q50924784 |
| | A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms. | Q51829787 |
| | Characteristics and clinical changes during hospitalization in bipolar and psychotic disorder patients with versus without substance-use disorders. | Q51847577 |
| | Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. | Q51942046 |
| | Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy. Italian Collaborative Study Group on the Outcome of Severe Mental Disorders. | Q51978180 |
| | Patterns of Psychotropic Drug Prescription for U.S. Patients With Diagnoses of Bipolar Disorders | Q54192185 |
| | Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages? | Q57470932 |
| | Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries | Q57470966 |
| | Monotherapy or polytherapy for epilepsy revisited: a quantitative assessment | Q71889284 |
| | A patient diary as a tool to improve medicine compliance | Q77360243 |
| | Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders | Q79535158 |
| | Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization | Q80000044 |
| | The increasing medical burden in bipolar disorder | Q81782161 |
| | Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension | Q94825038 |
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 5 | |
| P577 | publication date | 2013-05-03 | |
| P1433 | published in | International journal of bipolar disorders | Q27725397 |
| P1476 | title | Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data | |
| P478 | volume | 1 | |